← Leaderboards
Suzie H Pun
University Of Washington
$10,440,289
Attributed
$15,228,105
Total exposure
16
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,228,105 · 16
By mechanism
R01$11,748,269 · 6
R21$2,422,355 · 6
U01$922,438 · 1
U54$112,787 · 1
P41$12,256 · 1
R13$10,000 · 1
Top collaborators
- Philip J Horner7 shared
- Nathan J White7 shared
- Patrick S. Stayton5 shared
- Neil King2 shared
- Joshua R Smith2 shared
Most similar at University Of Washington
Same institution · by research overlap
- James D. Bryers$16,072,511
- Nathan J White$1,658,239
- Philip J Horner$7,784,899
- Jody W Deming$3,600,947
- John Everett Olerud$6,113,293
Others in their field
Top investigators on “Peptides”
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- John M Lachin · George Washington University$118,672,444
- David Heimbrook · Leidos Biomedical Research, Inc.$91,429,616
- Michael W Weiner · Northern California Institute Res &Educ$78,425,041
- Paul S. Aisen · Cognition Therapeutics, Inc.$69,846,203
- Rolf Apweiler · European Molecular Biology Laboratory$56,677,991
Research focus
PeptidesTechnologyIn VivoCellsIn VitroPolymersSiteInnovationEvaluationEngineeringToxic EffectDesignStructureMediatingBindingLigandsResponseMalignant NeoplasmsKineticsNucleic AcidsBaseLeadSurfaceIntravenous
Grant awards (46)
Engineering Technologies for Acute Trauma Care$580,017
R01 · FY2025 · EB · contact PI
An integrated polymeric carrier for subunit cancer vaccines$517,545
R01 · FY2025 · CA · contact PI
Traceless, aptamer-based cell isolation for cell therapy applications$342,725
R01 · FY2025 · EB · contact PI
An integrated polymeric carrier for subunit cancer vaccines$499,661
R01 · FY2024 · CA · contact PI
Traceless, aptamer-based cell isolation for cell therapy applications$335,484
R01 · FY2024 · EB · contact PI
An integrated polymeric carrier for subunit cancer vaccines$473,251
R01 · FY2023 · CA · contact PI
Traceless, aptamer-based cell isolation for cell therapy applications$342,498
R01 · FY2023 · EB · contact PI
Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2$455,938
U01 · FY2022 · AA · contact PI
An integrated polymeric carrier for subunit cancer vaccines$440,520
R01 · FY2022 · CA · contact PI
Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2$466,500
U01 · FY2021 · AA · contact PI
An integrated polymeric carrier for subunit cancer vaccines$429,683
R01 · FY2021 · CA · contact PI
2022 Drug Carriers in Medicine and Biology GRC/GRS$10,000
R13 · FY2021 · EB · contact PI
Synthetic Hemostats for Trauma Treatment$594,791
R01 · FY2020 · HL · contact PI
Synthetic Hemostats for Trauma Treatment$615,292
R01 · FY2019 · HL · contact PI
POTENTIATING BREAST CANCER THERAPIES BY TARGETING TUMOR-ASSOCIATED MACROPHAGE$249,049
R01 · FY2019 · CA · contact PI
Synthetic nucleocapsids: a new peptide library platform$196,840
R21 · FY2019 · CA · contact PI
Project 1: Targeted Nanoparticle Therapeutics for Treating Intracranial Disease$112,787
U54 · FY2019 · CA · contact PI
Synthetic Hemostats for Trauma Treatment$591,878
R01 · FY2018 · HL · contact PI
Ultrasound-aided gene transfer to direct cortical neurogenesis after brain injury$438,657
R01 · FY2018 · NS · contact PI
Synthetic nucleocapsids: a new peptide library platform$169,106
R21 · FY2018 · CA · contact PI
POTENTIATING BREAST CANCER THERAPIES BY TARGETING TUMOR-ASSOCIATED MACROPHAGE$153,624
R01 · FY2018 · CA · contact PI
Synthetic Hemostats for Trauma Treatment$509,625
R01 · FY2017 · HL · contact PI
Ultrasound-aided gene transfer to direct cortical neurogenesis after brain injury$435,092
R01 · FY2017 · NS · contact PI
POTENTIATING BREAST CANCER THERAPIES BY TARGETING TUMOR-ASSOCIATED MACROPHAGE$413,872
R01 · FY2017 · CA · contact PI
Ultrasound-aided gene transfer to direct cortical neurogenesis after brain injury$438,658
R01 · FY2016 · NS · contact PI
POTENTIATING BREAST CANCER THERAPIES BY TARGETING TUMOR-ASSOCIATED MACROPHAGE$399,073
R01 · FY2016 · CA · contact PI
Astrocyte-specific ligand discovery by phage display$261,000
R21 · FY2016 · NS · contact PI
Ultrasound-aided gene transfer to direct cortical neurogenesis after brain injury$414,267
R01 · FY2015 · NS · contact PI
POTENTIATING BREAST CANCER THERAPIES BY TARGETING TUMOR-ASSOCIATED MACROPHAGE$398,265
R01 · FY2015 · CA · contact PI
Synthetic hemostats for trauma treatment$231,750
R21 · FY2015 · EB · contact PI
Astrocyte-specific ligand discovery by phage display$217,500
R21 · FY2015 · NS
Ultrasound-aided gene transfer to direct cortical neurogenesis after brain injury$404,936
R01 · FY2014 · NS · contact PI
POTENTIATING BREAST CANCER THERAPIES BY TARGETING TUMOR-ASSOCIATED MACROPHAGE$357,017
R01 · FY2014 · CA · contact PI
Synthetic hemostats for trauma treatment$193,125
R21 · FY2014 · EB · contact PI
Non-viral gene delivery to neural progenitor cells in the SVZ$345,105
R01 · FY2012 · NS · contact PI
Non-viral gene delivery to neural progenitor cells in the SVZ$343,894
R01 · FY2011 · NS · contact PI
TUMOR-PENETRATING NANOPARTICLES$12,256
P41 · FY2011 · RR · contact PI
Non-viral gene delivery to neural progenitor cells in the SVZ$342,629
R01 · FY2010 · NS · contact PI
Novel Targeting Ligands for Sub-populations of monocyte-derived cells$234,000
R21 · FY2010 · HL · contact PI
Non-viral gene delivery to neural progenitor cells in the SVZ$341,161
R01 · FY2009 · NS · contact PI
Novel Targeting Ligands for Sub-populations of monocyte-derived cells$195,000
R21 · FY2009 · HL · contact PI
Nanoparticles for siRNA delivery to mammalian neurons$161,701
R21 · FY2007 · NS · contact PI
Nanoparticles for siRNA delivery to mammalian neurons$166,709
R21 · FY2006 · NS · contact PI
Nanoparticles for efficient delivery to solid tumors$111,028
R21 · FY2006 · CA · contact PI
Nanoparticles for siRNA delivery to mammalian neurons$170,896
R21 · FY2005 · NS
Nanoparticles for efficient delivery to solid tumors$113,700
R21 · FY2005 · CA